GlassScriptPhysician profile
Danny Barazi
NPI 1043883325
$2,955.13
in general payments reported to CMS, 2019-2025
25 companies · $1,546 in 2025
The $1,546 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $282 · 2024: $1,127 · 2025: $1,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,602 · Education: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,602.02 |
| Education | $353.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $599.21 | 2023-2025 | Fasenra, Breztri, Farxiga |
| Harmony Biosciences LLC | $431.66 | 2024-2025 | |
| United Therapeutics Corporation | $329.14 | 2023-2025 | Tyvaso, Tyvaso, Remodulin |
| Glaxosmithkline, LLC. | $236.46 | 2024-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $226.02 | 2024-2025 | Ofev, Jascayd |
| Jazz Pharmaceuticals INC. | $167.72 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $132.97 | 2024-2025 | Dupixent |
| Axsome Therapeutics, INC. | $106.85 | 2024-2025 | Sunosi |
| Genzyme Corporation | $88.87 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.96 | 2024-2025 | |
| Inspire Medical Systems, INC. | $65.40 | 2025 | Inspire |
| Mylan Specialty L.P. | $60.20 | 2024 | Yupelri |
| Avadel Cns Pharmaceuticals, LLC | $57.15 | 2024-2025 | Lumryz |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.06 | 2023 | Lifevest |
| Takeda Pharmaceuticals U.S.A., INC. | $49.25 | 2024-2025 | Glassia |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $47.37 | 2024 | Assure Wcd |
| Insmed, INC. | $45.08 | 2025 | Arikayce, Brinsupri |
| Novartis Pharmaceuticals Corporation | $36.43 | 2023-2024 | |
| Baxter Healthcare | $36.25 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Biotronik INC. | $22.79 | 2023 | |
| Viatris Specialty LLC | $21.15 | 2025 | Yupelri |
| Inogen, INC. | $16.67 | 2025 | |
| Electromed, INC. | $16.00 | 2024 | Smartvest |
| E.R. Squibb & Sons, L.L.C. | $15.32 | 2023 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $14.15 | 2024 | Uptravi, Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Barazi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.